Companies

RECURSION PHARMACEUTICALS, INC. (RXRX) SEC filings

CIK 0001601830 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2022FY2021
Revenue (USD)74.7 M39.8 M
Net income (USD)-87.0 M-61.9 M
Diluted EPS (USD/shares)-1.44-1.36

Latest filings

FiledFormDescriptionPeriod
2026-10-15424B5424B5
2026-10-158-K8-K items 1.01,2.02,7.01,8.01,9.012026-10-15
2026-10-15424B5424B5
2026-10-074FORM 42026-10-06
2026-10-074FORM 42026-10-06
2026-10-06144144
2026-10-06144144
2026-10-024FORM 42026-10-01
2026-10-024FORM 42026-10-01
2026-09-218-K8-K items 1.012026-09-15
2026-09-164FORM 42026-09-15
2026-09-104FORM 42026-09-08
2026-09-08144144
2026-09-024FORM 42026-09-01
2026-09-01144144
2026-08-21144144
2026-08-20144144
2026-08-19144144
2026-08-184FORM 42026-08-17
2026-08-184FORM 42026-08-17
2026-08-184FORM 42026-08-17
2026-08-18144144
2026-08-13144144
2026-08-12144144
2026-08-10144144

Forms on file (last 1,000): 4 477, 144 237, 8-K 85, 3 23, 10-Q 17, DEFA14A 15, SC 13G/A 14, SCHEDULE 13G/A 10. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=RXRX (0.002 USD), /gw/filings/filings?ticker=RXRX&form=8-K, /gw/filings/facts?ticker=RXRX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange